Enzo Biochem - 40 Year Stock Price History | ENZ

Historical daily share price chart and data for Enzo Biochem since 1980 adjusted for splits. The latest closing stock price for Enzo Biochem as of January 22, 2020 is 2.61.
  • The all-time high Enzo Biochem stock closing price was 122.00 on January 21, 2000.
  • The Enzo Biochem 52-week high stock price is 4.46, which is 70.9% above the current share price.
  • The Enzo Biochem 52-week low stock price is 2.40, which is 8% below the current share price.
  • The average Enzo Biochem stock price for the last 52 weeks is 3.30.
Enzo Biochem Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.5779 2.7600 2.7600 2.4200 2.6100 -0.76%
2019 3.3306 2.8000 4.3100 2.5400 2.6300 -5.40%
2018 5.2278 8.2500 8.3600 2.4600 2.7800 -65.89%
2017 9.2622 7.1400 11.7900 6.4000 8.1500 17.44%
2016 5.5990 4.6900 7.4800 4.0600 6.9400 54.22%
2015 3.3382 4.4500 4.9500 2.4300 4.5000 1.35%
2014 4.4767 2.9200 6.0800 2.6900 4.4400 52.05%
2013 2.4717 2.7500 3.1000 1.9400 2.9200 8.15%
2012 2.2276 2.3700 3.0500 1.4600 2.7000 20.54%
2011 3.5622 5.5000 5.7900 1.9900 2.2400 -57.58%
2010 4.8886 5.6700 6.6700 3.3700 5.2800 -1.86%
2009 5.0182 5.1000 7.6600 2.9000 5.3800 10.02%
2008 9.3999 12.9800 14.8300 3.5000 4.8900 -61.62%
2007 14.3258 14.5700 18.6500 10.0500 12.7400 -10.72%
2006 12.8201 12.5500 16.0000 9.3000 14.2700 14.90%
2005 15.4169 19.3000 19.3000 12.4200 12.4200 -36.21%
2004 16.2483 17.9500 20.4500 11.7100 19.4700 8.71%
2003 17.7648 14.6000 28.4300 11.5200 17.9100 27.93%
2002 16.6054 24.5500 25.7200 11.6500 14.0000 -40.43%
2001 22.9783 21.8100 34.9800 13.9500 23.5000 -5.55%
2000 53.9979 44.0000 122.0000 20.4400 24.8800 -45.91%
1999 17.7067 10.3800 46.8800 8.1250 46.0000 346.17%
1998 12.2603 14.6300 16.2500 6.5000 10.3100 -29.53%
1997 15.9713 18.5000 20.6300 13.0000 14.6300 -19.26%
1996 17.3435 19.7500 21.1300 14.2500 18.1200 -5.87%
1995 14.2192 11.3800 23.7500 9.6250 19.2500 72.96%
1994 12.4075 16.0000 19.3800 7.7500 11.1300 -29.91%
1993 10.8082 7.7500 19.8800 6.5000 15.8800 115.32%
1992 5.0900 3.3700 7.5000 3.2500 7.3750 96.67%
1991 1.6484 1.8800 7.8800 0.5000 3.7500 76.06%
1990 3.0223 3.8700 4.5000 1.7500 2.1300 -41.16%
1989 3.6294 3.1300 4.8700 2.6300 3.6200 11.38%
1988 3.9506 4.0000 4.8700 2.5000 3.2500 -13.33%
1987 8.4392 8.7500 12.1200 3.2500 3.7500 -57.14%
1986 12.7321 12.1200 18.7500 8.3800 8.7500 -29.26%
1985 14.1660 15.2500 21.0000 10.3700 12.3700 -17.53%
1984 16.3823 25.6200 26.2500 12.2500 15.0000 -39.69%
1983 24.7116 16.2467 33.5000 16.2467 24.8700 40.77%
1982 10.3396 10.5000 17.6667 5.5000 17.6667 66.98%
1981 9.2933 3.6233 15.0800 3.4567 10.5800 192.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.120B $0.081B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $141.178B 16.26
CSL (CSLLY) Australia $94.641B 0.00
Gilead Sciences (GILD) United States $79.236B 9.82
Vertex Pharmaceuticals (VRTX) United States $60.170B 61.42
Biogen (BIIB) United States $51.821B 8.89
Illumina (ILMN) United States $48.265B 52.96
Regeneron Pharmaceuticals (REGN) United States $39.933B 17.49
Alexion Pharmaceuticals (ALXN) United States $25.008B 12.35
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.764B 0.00
Seattle Genetics (SGEN) United States $18.624B 0.00
Incyte (INCY) United States $16.941B 39.33
BioMarin Pharmaceutical (BMRN) United States $15.726B 0.00
Genmab (GNMSF) Denmark $13.806B 60.98
Alnylam Pharmaceuticals (ALNY) United States $13.154B 0.00
Galapagos (GLPG) Belgium $13.084B 33.71
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
Exact Sciences (EXAS) United States $11.153B 0.00
BeiGene (BGNE) Cayman Islands $10.362B 0.00
Sarepta Therapeutics (SRPT) United States $9.168B 0.00
Bio-Techne Corp (TECH) United States $8.442B 56.51
BioNTech SE (BNTX) Germany $8.268B 0.00
QIAGEN (QGEN) Netherlands $8.042B 26.22
Guardant Health (GH) United States $7.861B 0.00
Amarin (AMRN) Ireland $7.527B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.164B 18.21
Moderna (MRNA) United States $6.978B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.680B 0.00
Reata Pharmaceuticals (RETA) United States $6.446B 0.00
Exelixis (EXEL) United States $6.004B 16.89
Ascendis Pharma (ASND) Denmark $5.895B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.844B 0.00
Bluebird Bio (BLUE) United States $5.302B 0.00
Repligen (RGEN) United States $5.258B 95.29
China Biologic Products (CBPO) China $4.581B 25.81
MorphoSys AG (MOR) Germany $4.187B 0.00
Blueprint Medicines (BPMC) United States $3.923B 0.00
Mirati Therapeutics (MRTX) United States $3.669B 0.00
Immunomedics (IMMU) United States $3.631B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.410B 0.00
NeoGenomics (NEO) United States $3.381B 179.89
MyoKardia (MYOK) United States $3.363B 0.00
Adaptive Biotechnologies (ADPT) United States $3.332B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.298B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.208B 0.00
Zai Lab (ZLAB) China $3.030B 0.00
Emergent Biosolutions (EBS) United States $2.959B 29.40
Alkermes (ALKS) Ireland $2.918B 0.00
Genmab (GMAB) Denmark $2.907B 5.99
Halozyme Therapeutics (HALO) United States $2.873B 0.00
Acceleron Pharma (XLRN) United States $2.871B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.859B 0.00
UniQure (QURE) Netherlands $2.712B 0.00
Amicus Therapeutics (FOLD) United States $2.493B 0.00
Epizyme (EPZM) United States $2.369B 0.00
Arena Pharmaceuticals (ARNA) United States $2.276B 5.29
RA PHARMCTL INC (RARX) United States $2.209B 0.00
Denali Therapeutics (DNLI) United States $2.114B 0.00
Myriad Genetics (MYGN) United States $2.113B 31.22
Principia Biopharma (PRNB) United States $1.977B 0.00
Zymeworks (ZYME) Canada $1.880B 0.00
Insmed (INSM) United States $1.866B 0.00
Fate Therapeutics (FATE) United States $1.844B 0.00
Arvinas (ARVN) United States $1.714B 0.00
REGENXBIO (RGNX) United States $1.703B 0.00
Akcea Therapeutics (AKCA) United States $1.628B 0.00
Ligand Pharmaceuticals (LGND) United States $1.576B 30.32
Editas Medicine (EDIT) United States $1.535B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.532B 0.00
Alector (ALEC) United States $1.516B 0.00
Intra-Cellular Therapies (ITCI) United States $1.409B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.377B 0.00
Coherus BioSciences (CHRS) United States $1.352B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.350B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.203B 0.00
Zealand Pharma (ZEAL) Denmark $1.168B 0.00
DBV Technologies S.A (DBVT) France $1.136B 0.00
Codexis (CDXS) United States $1.029B 0.00
Revance Therapeutics (RVNC) United States $0.997B 0.00
PHARMA MAR SA (PHMMF) Spain $0.965B 0.00
Sangamo Therapeutics (SGMO) United States $0.958B 0.00
Mesoblast (MESO) Australia $0.953B 0.00
Pharming Group (PHGUF) Netherlands $0.909B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.902B 0.00
Heska (HSKA) United States $0.827B 211.32
ZIOPHARM Oncology Inc (ZIOP) United States $0.807B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.800B 6.72
GENFIT S.A (GNFT) France $0.776B 0.00
Cellectis S.A (CLLS) France $0.765B 0.00
Vericel (VCEL) United States $0.749B 279.42
Adverum Biotechnologies (ADVM) United States $0.747B 0.00
Twist Bioscience (TWST) United States $0.736B 0.00
ANI Pharmaceuticals (ANIP) United States $0.735B 12.54
Cytokineticsorporated (CYTK) United States $0.717B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
Sorrento Therapeutics (SRNE) United States $0.705B 0.00
Intellia Therapeutics (NTLA) United States $0.702B 0.00
UROGEN PHARMA (URGN) United States $0.693B 0.00
Retrophin (RTRX) United States $0.688B 0.00
Cara Therapeutics (CARA) United States $0.675B 0.00
Anika Therapeutics (ANIK) United States $0.655B 21.25
AC Immune SA (ACIU) Switzerland $0.638B 14.77
NantKwest (NK) United States $0.616B 0.00
Kadmon Holdings (KDMN) United States $0.594B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Prothena (PRTA) Ireland $0.544B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.540B 0.00
Precision BioSciences (DTIL) United States $0.540B 0.00
Agenus (AGEN) United States $0.536B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.515B 0.00
BioDelivery Sciences (BDSI) United States $0.515B 0.00
Clovis Oncology (CLVS) United States $0.513B 0.00
Dynavax Technologies (DVAX) United States $0.511B 0.00
Bellus Health (BLU) Canada $0.469B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.460B 0.00
Cel-Sci (CVM) United States $0.444B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.433B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.433B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.430B 2.98
AnaptysBio (ANAB) United States $0.422B 0.00
Merus (MRUS) Netherlands $0.399B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.390B 0.00
Gritstone Oncology (GRTS) United States $0.386B 0.00
Mersana Therapeutics (MRSN) United States $0.384B 0.00
Kindred Biosciences (KIN) United States $0.383B 0.00
Puma Biotechnology (PBYI) United States $0.381B 0.00
Avid Bioservices (CDMO) United States $0.366B 0.00
PDL BioPharma (PDLI) United States $0.365B 9.14
Inovio Pharmaceuticals (INO) United States $0.356B 0.00
MannKind (MNKD) United States $0.352B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Pfenex (PFNX) United States $0.347B 0.00
Stemline Therapeutics (STML) United States $0.347B 0.00
Cue Biopharma (CUE) United States $0.345B 0.00
CytomX Therapeutics (CTMX) United States $0.339B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
OSMOTICA PHARM (OSMT) United States $0.335B 0.00
Syros Pharmaceuticals (SYRS) United States $0.332B 0.00
Compugen (CGEN) Israel $0.327B 0.00
Novavax (NVAX) United States $0.315B 0.00
Albireo Pharma (ALBO) United States $0.313B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
VBI Vaccines (VBIV) United States $0.296B 0.00
Geron (GERN) United States $0.282B 0.00
Sutro Biopharma (STRO) United States $0.280B 0.00
IVERIC Bio (ISEE) United States $0.280B 0.00
Kamada (KMDA) Israel $0.276B 8.06
WAVE Life Sciences (WVE) Singapore $0.275B 0.00
ADMA Biologics Inc (ADMA) United States $0.263B 0.00
Prometic Life Sciences (LMNL) Canada $0.261B 0.00
ChromaDex (CDXC) United States $0.260B 0.00
Biofrontera AG (BFRA) Germany $0.254B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.235B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.227B 0.00
Affimed (AFMD) Germany $0.221B 0.00
Exicure (XCUR) United States $0.221B 0.00
Five Prime Therapeutics (FPRX) United States $0.220B 0.00
Cerecor (CERC) United States $0.217B 0.00
XOMA (XOMA) United States $0.217B 0.00
Theratechnologies (THTX) Canada $0.210B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.210B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.203B 0.00
Protagonist Therapeutics (PTGX) United States $0.202B 0.00
Athersys (ATHX) United States $0.201B 0.00
Arbutus Biopharma (ABUS) Canada $0.193B 0.00
Fortress Biotech (FBIO) United States $0.191B 0.00
Windtree Therapeutics (WINT) United States $0.183B 0.00
CorMedix Inc (CRMD) United States $0.182B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.177B 0.00
ARAVIVE, INC (ARAV) United States $0.176B 0.00
Alcobra (ARCT) United States $0.175B 0.00
Spero Therapeutics (SPRO) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.173B 0.00
Selecta Biosciences (SELB) United States $0.168B 0.00
TELA Bio (TELA) United States $0.166B 0.00
PHASEBIO PHARMA (PHAS) United States $0.162B 0.00
Palatin Technologies (PTN) United States $0.162B 4.41
Dyadic (DYAI) United States $0.161B 0.00
Menlo Therapeutics (MNLO) United States $0.157B 0.00
Aptinyx (APTX) United States $0.156B 0.00
Applied Genetic Technologies (AGTC) United States $0.150B 0.00
Strongbridge Biopharma (SBBP) United States $0.147B 3.94
Abeona Therapeutics (ABEO) United States $0.142B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Verastem (VSTM) United States $0.133B 0.00
VTv Therapeutics (VTVT) United States $0.133B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.127B 6.55
Clearside Biomedical (CLSD) United States $0.127B 0.00
Liquidia Technologies (LQDA) United States $0.125B 0.00
Northwest Biotherapeutics (NWBO) United States $0.124B 0.00
Arsanis (XFOR) United States $0.124B 0.00
Celyad SA (CYAD) Belgium $0.123B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.121B 0.00
Aduro Biotech (ADRO) United States $0.114B 0.00
Happiness Biotech Group (HAPP) China $0.112B 0.00
Antibe Therapeutics (ATBPF) Canada $0.111B 0.00
OvaScience (MLND) United States $0.106B 0.00
Synlogic (SYBX) United States $0.103B 0.00
SESEN BIO, INC (SESN) United States $0.101B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.099B 0.00
Proteostasis Therapeutics (PTI) United States $0.098B 0.00
Acorda Therapeutics (ACOR) United States $0.098B 0.00
AIT Therapeutics (XAIR) United States $0.096B 0.00
Catalyst Biosciences (CBIO) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
NewLink Genetics (NLNK) United States $0.084B 0.00
Emmaus Life Sciences (EMMA) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.082B 5.30
Trevena (TRVN) United States $0.082B 0.00
Prima BioMed (IMMP) Australia $0.082B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Vaccinex (VCNX) United States $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.075B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.074B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Curis (CRIS) United States $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Organovo Holdings (ONVO) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
Soligenix (SNGX) United States $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.047B 0.00
Evogene (EVGN) Israel $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.042B 0.00
Celsion (CLSN) United States $0.038B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
BioCardia (BCDA) United States $0.037B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Bionano Genomics (BNGO) United States $0.033B 0.00
Unum Therapeutics (UMRX) United States $0.032B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.031B 0.00
AmpliPhi Biosciences (ARMP) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
VIVUS (VVUS) United States $0.029B 0.00
AEterna Zentaris (AEZS) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.018B 0.00
Advaxis (ADXS) United States $0.018B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
BioPharmX (BPMX) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.005B 0.00